Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With the Acute Respiratory Distress Syndrome and Acute Renal Failure

NCT01239966 is registered in ClinicalTrials.gov with Hôpital Européen Marseille as lead sponsor.

NCT NCT01239966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01239966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With the Acute Respiratory Distress Syndrome and Acute Renal Failure
Lead sponsor
Hôpital Européen Marseille
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
June 30, 2015
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure, acute respiratory distress syndrome